Todd Christopher Longsworth - 08 Mar 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Reporting relationship: General Counsel
Issuer ticker: NVCR
Reported as of: 08 Mar 2022
Net transaction value: -$163,964
SEC form: 4
Accepted by SEC: 09 Mar 2022, 15:50:03 UTC
Prior SEC filing: 07 Mar 2022
Source filing: View source filing
Reporting owner signature: By: /s/ Steven Robbins, Attorney in Fact for Todd Longsworth

Key filing fact

Todd Christopher Longsworth filed Form 4 for NovoCure Ltd (NVCR) on 09 Mar 2022.

Key facts

This page summarizes Todd Christopher Longsworth's Form 4 filing for NovoCure Ltd (NVCR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Mar 2022, 15:50.

Change

Previous filing in this sequence was filed on 07 Mar 2022.
Current net transaction value: -$163,964.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVCR transaction

Ordinary Shares

Sale

Transaction value: $163,964
Shares: -2,339
Change %: -3.6%
Price: $70.10
Shares after: 62,462
Date: 08 Mar 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.